Cholesterol and Blood Pressure
Turmeric and Circulation
The discovery of spices
Deodhar, S., Sethi, R., Srimal, R. (1980). Preliminary study on activity of curcumin (diferuloyl methane). Indian J Med Res, 71:632-634
Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine Complex, during extended administration in osteoarthritis patients. Alternative Medicine Review 2010
American Cancer Society. Turmeric. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/herbsvitaminsandminerals/turmeric.
Banafshe HR, et al. Effect of curcumin on diabetic peripheral neuropathic pain: Possible involvement of opioid system. Eur J Pharmacol 2013;
Cancer Research UK. Can turmeric prevent or treat cancer? Available at: http://www.cancerresearchuk.org/cancer-help/about-cancer/cancer-questions/can-turmeric-prevent-bowel-cancer.
NHS. Anticoagulant medicine – side effects. Available at: http://www.nhs.uk/Conditions/Anticoagulant-medicines/Pages/Side-effects.aspx.
NHS. Side effects of corticosteroids. Available at: http://www.nhs.uk/Conditions/Corticosteroid-(drugs)/Pages/Sideeffects.aspx
Ng SC, et al. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009; 15(6): 935-50.
R Srivastava, et al. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneimittelforschung 1986
Sanmukhani J, et al. Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial. Phytother Res 2013
Teayoun K, et al. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009;
Usharani P, et al. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008;
Yasunari Takada, et al. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004; http://www.nature.com/onc/journal/v23/n57/full/1208169a.html